abagovomab 23
abciximab 24
abituzumab 21
abrilumab 18
actoxumab 13
adalimumab 17
aducanumab 10
afasevikumab 15
alacizumab_pegol 11
alemtuzumab 21
alirocumab 20
amatuximab 35
andecaliximab 21
anifrolumab 18
anrukinzumab 17
aprutumab 17
aprutumab_ixadotin 17
arcitumomab 18
ascrinvacumab 4
atezolizumab 16
atinumab 16
avelumab 12
basiliximab 24
bavituximab 29
begelomab 20
benralizumab 21
bevacizumab_beta 19
bezlotoxumab 13
bimagrumab 10
bleselumab 12
blinatumomab 25
blosozumab 28
bococizumab 15
brazikumab 14
brentuximab_vedotin 30
briakinumab 17
brodalumab 7
brolucizumab 25
brontictuzumab 21
burosumab 17
cabiralizumab 24
camrelizumab 10
canakinumab 20
cantuzumab_ravtansin 36
carlumab 13
carotuximab 24
cergutuzumab_amunaleukin2 23
cergutuzumab_amunaleukin 23
certolizumab_pegol 25
cetiximab 38
citatuzumab_bogatox 25
cixutumumab 23
clivatuzumab_tetraxetan 14
codrituzumab 28
conatumumab 11
concizumab 28
crenezumab 19
crizanlizumab 25
crotedumab 21
dacetuzumab 21
daclizumab 10
dalotuzumab 30
dapirolizumab_pegol 22
daratumumab 13
dectrekumab 10
demcizumab 21
denosumab 8
depatuxizumab 21
depatuxizumab_mafodotin 21
dezamizumab 13
dinutuximab 29
diridavumab 18
domagrozumab 15
drozitumab 12
duligotuzumab 20
durvalumab 8
dusigitumab 13
efalizumab 32
efungumab 26
eldelumab 14
elezanumab 19
elgemtumab 11
elotuzumab 14
emactuzumab 15
emapalumab 25
emibetuzumab 14
enavatuzumab 24
enfortumab_vedotin 14
enoblituzumab 17
enokizumab 23
enoticumab 17
ensituximab 25
eptinezumab 16
erenumab 19
etaracizumab 15
etrolizumab 22
evinacumab 22
evolocumab 12
farletuzumab 3
fasinumab 19
fezakinumab 19
fibatuzumab 9
ficlatuzumab 19
firivumab 28
flanvotumab 15
fletikumab 14
foralumab 12
foravirumab 14
fremanezumab 28
fresolimumab 16
fulranumab 20
futuximab 18
galcanezumab 16
ganitumab 20
gantenerumab 10
gemetuzumab 22
gemtuzumab2 24
gemtuzumab 19
gevokizumab 21
girentuximab 27
glembatumumab 16
glembatumumab_vedotin 16
guselkumab 20
ibalizumab 21
ibritumomab 22
icrucumab 9
idarucizumab 28
ifabotuzumab 9
imalumab 17
imgatuzumab 16
inclacumab 20
indatuximab_ravtansin 22
indusatumab 11
inebilizumab 22
intetumumab 12
iodine_girentuximab 28
ipilimumab 3
iratumumab 6
isatuximab 27
itolizumab 22
ixekizumab 30
labetuzumab_govitecan 19
lambrolizumab 23
lampalizumab 21
lanadelumab 18
landogrozumab 18
laprituximab 23
lebrikizumab 32
lendalizumab 23
lenzilumab 15
lifastuzumab_vedotin 24
ligelizumab 21
lilotomab 31
lirilumab 22
lodelcizumab 16
lokivetmab 22
lorvotuzumab_mertansin 22
lucatumumab 28
lumretuzumab 15
lupartumab 15
lutikizumab 18
margetuximab 29
milatuzumab 36
mirvetuximab 25
mirvetuximab_soravtansin 25
modotuximab 32
mogamulizumab 28
monalizumab 16
motavizumab 31
moxetumomab_pasudotox 23
namilumab 16
naratuximab 27
naratuximab_emtansin 27
narnatumab 15
navicixizumab2 25
navicixizumab 23
navivumab 30
necitumumab 10
nemolizumab 21
nesvacumab 16
nivolumab 11
obiltoxaximab 19
obinutuzumab 31
ocaratuzumab 20
ofatumumab 18
olaratumab 18
olokizumab 23
omalizumab 19
onartuzumab 20
ontuxizumab 21
opicinumab 13
orticumab 13
otelixizumab 35
oxelumab 12
ozanezumab 29
pamrevlumab 11
panobacumab 23
parsatuzumab 24
pasotuxizumab 22
pateclizumab 15
patritumab 15
pembrolizumab 23
perakizumab 23
pidilizumab 14
pinatuzumab_vedotin 19
plozalizumab 26
pogalizumab 20
polatuzumab_vedotin 22
ponezumab 31
prezalumab 14
pritoxaximab 23
quilizumab 21
racotumomab 25
radretumab 14
ralpancizumab 20
ramucirumab 13
ranevetmab 24
ranibizumab 19
refanezumab 21
remtolumab 18
rilotumumab 13
rinucumab 14
risankizumab 29
rituximab 16
rivabazumab 18
robatumumab 20
roledumab 25
romosozumab 17
rontalizumab 19
rosmantuzumab 20
rozanolixizumab 20
sacituzumab 24
sacituzumab_govitecan 24
samalizumab 23
sapelizumab 23
sarilumab 17
secukinumab 11
seribantumab 16
setoxaximab 35
sifalimumab 8
siltuximab 17
simtuzumab 24
sirukumab 12
solanezumab 27
solitomab 19
stamulumab 16
suptavumab 22
suvizumab 18
tabalumab 10
tadocizumab 12
tamtuvetmab 29
tanezumab 20
tarextumab 10
tavolixizumab 13
telisotuzumab 24
teplizumab 16
tesidolumab 20
tezepelumab 23
tigatuzumab 15
tildrakizumab 19
timolumab 12
tisotumab 9
tosatoxumab 30
tositumomab 22
tralokinumab 21
trastuzumab 23
tregalizumab 22
trevogrumab 11
ublituximab 26
urelumab 17
ustekinumab 25
utomilumab 26
vadastuximab 20
vadastuximab_talirin 20
vandortuzumab_vedotin 14
vantictumab 19
vanucizumab2 19
vanucizumab 26
varlilumab 14
vatelizumab 17
vedolizumab 22
veltuzumab 10
vesencumab 10
vorsetuzumab 19
vorsetuzumab_mafodotin 19
vunakizumab 27
xentuzumab 17
zatuximab 32
